Negotiated Procedure Without Prior Publication Of The Announcement For The Supply Of The Opdualag Drug Of The Bristol Myers Squibb Srl Company For The Duration Of 48 Months In Favor Of The South Tyrol Health Authority

Name: Negotiated Procedure Without Prior Publication Of The Announcement For The Supply Of The Opdualag Drug Of The Bristol Myers Squibb Srl Company For The Duration Of 48 Months In Favor Of The South Tyrol Health Authority
Start: 2025-05-23
End: -0001-11-30
Location: Azienda Sanitaria dell’Alto Adige - Ripartizione acquisti

Azienda Sanitaria dell’Alto Adige - Ripartizione acquisti Italy has Released a tender for Negotiated Procedure Without Prior Publication Of The Announcement For The Supply Of The Opdualag Drug Of The Bristol Myers Squibb Srl Company For The Duration Of 48 Months In Favor Of The South Tyrol Health Authority in Pharmaceuticals. The tender was released on May 23, 2025.

Country - Italy

Summary - Negotiated Procedure Without Prior Publication Of The Announcement For The Supply Of The Opdualag Drug Of The Bristol Myers Squibb Srl Company For The Duration Of 48 Months In Favor Of The South Tyrol Health Authority

Deadline - login to view

GT reference number - 109414251

Product classification - Antineoplastic and immunomodulating agents

Organization Details:

Address - Italy

Contact details - 565656565

Tender notice no. - 76454545

GT Ref Id - 109414251

Document Type - Tender Notices

Notice Details and Documents:

Description - A contract has been awarded by Azienda Sanitaria dell’Alto Adige - Ripartizione acquisti for Negotiated Procedure Without Prior Publication Of The Announcement For The Supply Of The Opdualag Drug Of The Bristol Myers Squibb Srl Company For The Dura tion Of 48 Months In Favor Of The South Tyrol Health Authority to Bristol-Myers Squibb S.r.l. Piazzale dell'Industria.

Gt Ref Id - 109414251

Deadline - Nov 30, -0001

View more tenders for

Antineoplastic and immunomodul Tenders Italy Tenders

Similar Tenders :

Summary:

Medicinal Products Containing Kladribine, Fludarabin, Alarabin, Fluoruracil, Capcitabin, Vinorelbine, Ethoposide And Kabazitaxel

Summary:

Ssc Supply Of Perutuzumab More Trastuzumab

Summary:

Framework Agreement For The Supply, Respectful Of The Environment, Of Biological Medicines With Biosimilar, For Several Autonomous Communities, Centers Of The National Institute Of Health Management (Ingesa) In Ceuta And Melilla And State Administration Organizations

Summary:

Pembrolizumab

Summary:

Daratumumab

Create Account

Join to access thousands of business opportunities

Quick Links

Why Us

3,00,000 +

Users

190 +

Countries Covered

5,00,000 +

Agencies Tracked

50,000 +

Notices Daily

90 Million +

Database